Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Tag: Aravax
FDA Green Lights Phase 2 Trials of PVX108, a Novel Peptide-Driven...
News Wire ~ 3rd Party Press Release
-
2022/03/04
Phase 2 study of candidate from Aravax will commence in the US and Australia.
Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...
News Wire ~ 3rd Party Press Release
-
2019/06/05
Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma.
Institute Receives $5M Grant to Study Personalized Treatments for Peanut Allergy
Dave Bloom
-
2018/01/30
What they discover could guide the design of a new strategy for immune intervention.
Novel Peanut Allergy Vaccine Begins Phase I Clinical Trials
Dave Bloom
-
2017/05/22
Vaccine uses peptides selected from parts of the peanut protein that do not cause life-threatening anaphylactic reactions.